MICHAEL POWELL - 09 Aug 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Issuer symbol
N/A
Transactions as of
09 Aug 2021
Net transactions value
$0
Form type
4
Filing time
10 Aug 2021, 16:05:28 UTC
Previous filing
17 Jun 2021
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 09 Aug 2021 Common Stock 30,000 $5.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on August 9, 2021 with respect to 30,000 shares of the Issuer's common stock and shall vest in 12 equal monthly installments, subject to the Reporting Person's continuous service to the Issuer on each such date.